CompletedNot Applicable

Utility of 18F-FDG PET/CT for Suspected Infection in the Inpatient Setting: a Single Centre Retrospective Cohort Study

Australia266 participantsStarted 2022-01-04

Plain-language summary

Retrospective cohort study of inpatients at a South Australian tertiary hospital who underwent 18F FDG-PET/CT for investigation of undifferentiated fever or inflammatory syndrome. The aim is to investigate the utility of FDG-PET/CT in the investigation of suspected infection in hospitalised adults. To establish the rate at which FDG-PET/CT contributes to a diagnosis, and how this impacts clinical management and outcomes. From this, to develop further understanding of for which patients this imaging modality contributes meaningfully to outcomes.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Inpatient at the Royal Adelaide Hospital * FDG-PET/CT between 1st January 2022 - 31st December 2023 * Imaging request query included: infect\* AND/OR Fever of Unknown Origin OR FUO AND/OR Pyrexia of Unknown Origin OR PUO AND/OR inflammat\* Exclusion Criteria: * \- Outpatient PET/CT * Comparison imaging for established diagnosed infection * PET/CT intended for evaluation of malignancy * Evaluation of presumed or confirmed infective endocarditis * Age less than 18 years

What they're measuring

Diagnostic yield

Timeframe: 30 days

Trial details

NCT IDNCT07430475

SponsorUniversity of Adelaide

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-01-29

View on ClinicalTrials.gov More Fever of Unknown Origin trials